The Biden Public Option:
Debating Its Merits and Likelihood
Read the White Paper
In our latest non-partisan white paper, Douglas Hervey outlines presidential candidate Joe Biden’s healthcare public option plan, presents the cases for and against the proposal, and discusses the likelihood of its legislative passage.
This brief is among the first and most comprehensive analyses to address the topic. Cicero Group does not endorse platforms or policies; nor does it endorse the healthcare positions covered in these briefs. Rather, Cicero Group highlights perspectives across the political spectrum to further educate and engage readers in key areas that could impact their families, businesses, and communities.
Douglas Hervey is a principal at Cicero Group with an emphasis in healthcare and life science services. Douglas most recently worked as a senior director for Leavitt Partners. As a senior director, Douglas enabled healthcare entities to more effectively aggregate data, automate research processes, and make sound growth-oriented strategic and investment decisions. He has worked on over 200 healthcare private equity investment deals, within 80 unique healthcare sub-segments, for over 40 investment funds.
Douglas earned his bachelor’s degree in international relations at Brigham Young University, after which he earned his juris doctorate from the University of Pittsburgh. Douglas also holds an MBA from Brigham Young University, where he was a Hawes Scholar.